Cargando…
ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507737/ https://www.ncbi.nlm.nih.gov/pubmed/34639344 http://dx.doi.org/10.3390/ijerph181910039 |
_version_ | 1784581925845860352 |
---|---|
author | Domènech-Montoliu, Salvador Puig-Barberà, Joan Pac-Sa, Maria Rosario Vidal-Utrillas, Paula Latorre-Poveda, Marta Rio-González, Alba Del Ferrando-Rubert, Sara Ferrer-Abad, Gema Sánchez-Urbano, Manuel Aparisi-Esteve, Laura Badenes-Marques, Gema Cervera-Ferrer, Belén Clerig-Arnau, Ursula Dols-Bernad, Claudia Fontal-Carcel, Maria Gomez-Lanas, Lorna Jovani-Sales, David León-Domingo, Maria Carmen Llopico-Vilanova, Maria Dolores Moros-Blasco, Mercedes Notari-Rodríguez, Cristina Ruíz-Puig, Raquel Valls-López, Sonia Arnedo-Pena, Alberto |
author_facet | Domènech-Montoliu, Salvador Puig-Barberà, Joan Pac-Sa, Maria Rosario Vidal-Utrillas, Paula Latorre-Poveda, Marta Rio-González, Alba Del Ferrando-Rubert, Sara Ferrer-Abad, Gema Sánchez-Urbano, Manuel Aparisi-Esteve, Laura Badenes-Marques, Gema Cervera-Ferrer, Belén Clerig-Arnau, Ursula Dols-Bernad, Claudia Fontal-Carcel, Maria Gomez-Lanas, Lorna Jovani-Sales, David León-Domingo, Maria Carmen Llopico-Vilanova, Maria Dolores Moros-Blasco, Mercedes Notari-Rodríguez, Cristina Ruíz-Puig, Raquel Valls-López, Sonia Arnedo-Pena, Alberto |
author_sort | Domènech-Montoliu, Salvador |
collection | PubMed |
description | After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results. |
format | Online Article Text |
id | pubmed-8507737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85077372021-10-13 ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study Domènech-Montoliu, Salvador Puig-Barberà, Joan Pac-Sa, Maria Rosario Vidal-Utrillas, Paula Latorre-Poveda, Marta Rio-González, Alba Del Ferrando-Rubert, Sara Ferrer-Abad, Gema Sánchez-Urbano, Manuel Aparisi-Esteve, Laura Badenes-Marques, Gema Cervera-Ferrer, Belén Clerig-Arnau, Ursula Dols-Bernad, Claudia Fontal-Carcel, Maria Gomez-Lanas, Lorna Jovani-Sales, David León-Domingo, Maria Carmen Llopico-Vilanova, Maria Dolores Moros-Blasco, Mercedes Notari-Rodríguez, Cristina Ruíz-Puig, Raquel Valls-López, Sonia Arnedo-Pena, Alberto Int J Environ Res Public Health Article After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results. MDPI 2021-09-24 /pmc/articles/PMC8507737/ /pubmed/34639344 http://dx.doi.org/10.3390/ijerph181910039 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Domènech-Montoliu, Salvador Puig-Barberà, Joan Pac-Sa, Maria Rosario Vidal-Utrillas, Paula Latorre-Poveda, Marta Rio-González, Alba Del Ferrando-Rubert, Sara Ferrer-Abad, Gema Sánchez-Urbano, Manuel Aparisi-Esteve, Laura Badenes-Marques, Gema Cervera-Ferrer, Belén Clerig-Arnau, Ursula Dols-Bernad, Claudia Fontal-Carcel, Maria Gomez-Lanas, Lorna Jovani-Sales, David León-Domingo, Maria Carmen Llopico-Vilanova, Maria Dolores Moros-Blasco, Mercedes Notari-Rodríguez, Cristina Ruíz-Puig, Raquel Valls-López, Sonia Arnedo-Pena, Alberto ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title | ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title_full | ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title_fullStr | ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title_full_unstemmed | ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title_short | ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study |
title_sort | abo blood groups and the incidence of complications in covid-19 patients: a population-based prospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507737/ https://www.ncbi.nlm.nih.gov/pubmed/34639344 http://dx.doi.org/10.3390/ijerph181910039 |
work_keys_str_mv | AT domenechmontoliusalvador abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT puigbarberajoan abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT pacsamariarosario abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT vidalutrillaspaula abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT latorrepovedamarta abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT riogonzalezalbadel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT ferrandorubertsara abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT ferrerabadgema abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT sanchezurbanomanuel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT aparisiestevelaura abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT badenesmarquesgema abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT cerveraferrerbelen abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT clerigarnauursula abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT dolsbernadclaudia abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT fontalcarcelmaria abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT gomezlanaslorna abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT jovanisalesdavid abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT leondomingomariacarmen abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT llopicovilanovamariadolores abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT morosblascomercedes abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT notarirodriguezcristina abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT ruizpuigraquel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT vallslopezsonia abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy AT arnedopenaalberto abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy |